Literature DB >> 2787895

AIDS. Do antibodies enhance the infection of cells by HIV?

D P Bolognesi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2787895      PMCID： PMC7095050          DOI： 10.1038/340431a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells.

Authors:  J Homsy; M Meyer; M Tateno; S Clarkson; J A Levy
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

2.  Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells.

Authors:  M Tateno; F Gonzalez-Scarano; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells.

Authors:  P R Clapham; J N Weber; D Whitby; K McIntosh; A G Dalgleish; P J Maddon; K C Deen; R W Sweet; R A Weiss
Journal:  Nature       Date:  1989-01-26       Impact factor: 49.962

Review 4.  Pathogenesis of dengue: challenges to molecular biology.

Authors:  S B Halstead
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

5.  Antibody-dependent enhancement of human immunodeficiency virus type 1 infection.

Authors:  W E Robinson; D C Montefiori; W M Mitchell
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

6.  A new mechanism for the neutralization of enveloped viruses by antiviral antibody.

Authors:  S W Gollins; J S Porterfield
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

7.  Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry.

Authors:  A Takeda; C U Tuazon; F A Ennis
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728
  7 in total
  14 in total

1.  A human CD4+ T-cell line expresses functional CD64 (Fc gamma RI), CD32 (Fc gamma RII), and CD16 (Fc gamma RIII) receptors but these do not enhance the infectivity of HIV-1-IgG complexes.

Authors:  L McLain; N J Dimmock
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

Review 2.  Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.

Authors:  D C Montefiori
Journal:  Springer Semin Immunopathol       Date:  1997

3.  Protective efficacy of nonneutralizing monoclonal antibodies in acute infection with murine leukemia virus.

Authors:  S H Pincus; R Cole; R Ireland; F McAtee; R Fujisawa; J Portis
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 4.  Circulating immune complexes in HIV-infected persons.

Authors:  F E Krapf; M Herrmann; W Leitmann; B Schwartländer; J R Kalden
Journal:  Klin Wochenschr       Date:  1990-03-16

5.  Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.

Authors:  S H Pincus; K G Messer; D H Schwartz; G K Lewis; B S Graham; W A Blattner; G Fisher
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  Neutralizing-enhancing monoclonal antibody recognizes the denatured glycoprotein of viral haemorrhagic septicaemia virus.

Authors:  F Sanz; J M Coll
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 7.  Fc gamma receptors in cancer and infectious disease.

Authors:  M W Fanger; D V Erbe
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

8.  Expression and gene transcript of Fc receptors for IgG, HLA class II antigens and Langerhans cells in human cervico-vaginal epithelium.

Authors:  L A Hussain; C G Kelly; R Fellowes; E M Hecht; J Wilson; M Chapman; T Lehner
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

9.  Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro.

Authors:  G Baier; G Baier-Bitterlich; D J Looney; A Altman
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

10.  Vaccination with a live retrovirus: the nature of the protective immune response.

Authors:  R M Ruprecht; S Mullaney; L D Bernard; M A Gama Sosa; R C Hom; R W Finberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.